The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Mirtazapine 30 mg Film-Coated Tablets

30 milligram(s) Film-coated tablet

Accord Healthcare Ireland Ltd.PA2315/072/002

Main Information

Trade NameMirtazapine 30 mg Film-Coated Tablets
Active SubstancesMirtazapine
Strength30 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/072/002

Group Information

ATC CodeN06AX Other antidepressants
N06AX11 mirtazapine

Status

Authorised/WithdrawnAuthorised
Licence Issued17/02/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0061-033-015
Interchangeable List DocumentPDF of Interchangeable List
« Back